Bio-Bridge gains Japan patent

OAK BROOK - Bio-Bridge Science Inc., a biotechnology company engaged in the commercial development of vaccines and vaccine-related products announced Monday that the Japanese Patent Office has issued a patent regarding the use of the papilloma pseudovirus. Bio-Bridge Science has previously been granted patents relating to the technology in the United States and China.